日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775

乐伐替尼联合帕博利珠单抗治疗既往接受过治疗的晚期子宫内膜癌:随机、3期研究309/KEYNOTE-775的5年结果

Makker, Vicky; Colombo, Nicoletta; Casado, Antonio; Santin, Alessandro D; Colomba, Emeline; Miller, David S; Fujiwara, Keiichi; Pignata, Sandro; Yonemori, Kan; Kim, Yong Man; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Kristeleit, Rebecca; Nishio, Shin; Suzuki, Shiro; Guerra Alía, Eva M; Sanli, Ulus A; Selle, Frederic; Shikama, Ayumi; Martínez Rodríguez, Jorge L; Arik, Zafer; Arican, Ali; Sebastianelli, Alexandra; Yu, Zhou; McKenzie, Jodi; Kruger, Stephan; Meng, Robin; Okpara, Chinyere E; Lorusso, Domenica

Integrated mutational landscape analysis of endometrial stromal sarcoma

子宫内膜间质肉瘤的整合突变图谱分析

Hartwich, Tobias M P; Choi, Seungji; Hwang, Ayoung; Bellone, Stefania; Palmieri, Luca; Seo, Hae; Kim, Taekeun; Hong, Juhyeon; Krakstad, Camilla; Trovik, Jone; Stefansson, Ingunn M; Haugland, Hans Kristian; Greenman, Michelle; Ettorre, Victoria; Ottum, Sarah; Demirkiran, Cem; Yang-Hartwich, Yang; Buza, Natalia; Hui, Pei; Lopez, Salvatore; Cormio, Gennaro; Ramunno, Mariantonietta; Zito, Alfredo; Perrone, Emanuele; Fagotti, Anna; Fanfani, Francesco; Santoro, Angela; Ravaggi, Antonella; Bignotti, Eliana; Odicino, Franco; Ardighieri, Laura; Ratner, Elena; Angioli, Roberto; Perrone, Giuseppe; Luvero, Daniela; Conca, Beatrice; Choi, Jungmin; Schlessinger, Joseph; Santin, Alessandro D

Long lasting response to the combination of Avutometinib and Defactinib after progression on Binimetinib in a patient with recurrent low grade serous ovarian carcinoma - A case report

一例复发性低级别浆液性卵巢癌患者在接受比美替尼治疗后病情进展,随后接受阿武替尼和德法替尼联合治疗并获得长期疗效——病例报告

Ettorre, Victoria M; Palmieri, Luca; Ottum, Sarah; Greenman, Michelle; Santin, Alessandro D

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201

阿伐替尼±德法替尼治疗复发性低级别浆液性卵巢癌的疗效和安全性:ENGOT-OV60/GOG-3052/RAMP 201研究的主要分析

Banerjee, Susana N; Van Nieuwenhuysen, Els; Aghajanian, Carol; D'Hondt, Véronique; Monk, Bradley J; Clamp, Andrew; Prendergast, Emily; Oaknin, Ana; Ring, Kari; Colombo, Nicoletta; Holloway, Robert W; Rodrigues, Manuel; Chon, Hye Sook; Gourley, Charlie; Santin, Alessandro D; Thaker, Premal H; Gennigens, Christine; Newman, Gregg; Salinas, Erin; Youssoufian, Hagop; Moore, Kathleen N; Lustgarten, Stephanie; O'Malley, David M; Van Gorp, Toon; Grisham, Rachel N

Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma

NRG258 是一项随机 III 期试验,比较放化疗与单纯化疗治疗局部晚期子宫内膜癌的疗效,本研究的长期随访和总生存期如下:

Matei, Daniela E; Enserro, Danielle M; Randall, Marcus E; Mutch, David; Small, William; DiSilvestro, Paul A; Spirtos, Nick M; O'Malley, David M; Cantuaria, Guilherme H; Michelin, David; Waggoner, Steven; Shahin, Mark; Guntupalli, Saketh; Lara, Olivia; Ueland, Frederick R; Warshal, David; Bonebrake, Albert; Tewari, Krishnansu S; Tan, Annie; Powell, Matthew A; Walker, Joan L; Santin, Alessandro D; Kim, Jong Hyeok; Miller, David S

HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma

HER2/neu 作为子宫浆液性癌的信号传导和治疗标志物

Ettorre, Victoria M; Palmieri, Luca; Clemente, Valentino; Santin, Alessandro D

Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor

雌激素受体降解剂氟维司群联合 RAF/MEK 钳制剂阿伐替尼和 FAK 抑制剂治疗对化疗和芳香化酶抑制剂产生耐药性的低级别浆液性卵巢癌动物模型的临床前疗效

Demirkiran, Cem; Bellone, Stefania; Ettorre, Victoria M; Mansolf, Miranda; Hartwich, Tobias Max Philipp; McNamara, Blair; Greenman, Michelle; Yang-Hartwich, Yang; Ratner, Elena; Santin, Niccoló G; Sethi, Namrata; Palmieri, Luca; Coma, Silvia; Pachter, Jonathan A; Ottum, Sarah; Santin, Alessandro D

Personalized Treatment in Ovarian Cancer: A Review of Disease Monitoring, Biomarker Expression, and Targeted Treatments for Advanced, Recurrent Ovarian Cancers

卵巢癌的个体化治疗:晚期和复发性卵巢癌的疾病监测、生物标志物表达和靶向治疗综述

Ettorre, Victoria M; AlAshqar, Abdelrahman; Sethi, Namrata; Santin, Alessandro D

Co-expression of tissue factor, TROP2, and NECTIN4 in primary and matched metastatic cervical cancer lesions

原发性和匹配的转移性宫颈癌病变中组织因子、TROP2 和 NECTIN4 的共表达

Ulvang, Marit L; Kvile, Oda Fløtre; Berg, Hege F; Woie, Kathrine; Haldorsen, Ingfrid S; Santin, Alessandro D; Bertelsen, Bjørn I; Krakstad, Camilla; Halle, Mari Kyllesø

Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma

Datopotamab Deruxtecan(一种靶向滋养层细胞表面抗原2的抗体药物偶联物)在子宫浆液性癌中的临床前活性

Greenman, Michelle; Demirkiran, Cem; Bellone, Stefania; Hartwich, Tobias M P; McNamara, Blair; Ettorre, Victoria M; Santin, Niccolo G; Sethi, Namrata; Yang-Hartwich, Yang; Papatla, Katyayani; Ratner, Elena; Santin, Alessandro D